NCT06252168 (RAMI-Tomsk) is a clinical trial in Myocardial Infarction, Acute, sponsored by Tomsk National Research Medical Center of the Russian Academy of Sciences.

Who is sponsoring NCT06252168?

NCT06252168 is sponsored by Tomsk National Research Medical Center of the Russian Academy of Sciences.

What condition does NCT06252168 study?

NCT06252168 studies Myocardial Infarction, Acute.

Is NCT06252168 still recruiting?

NCT06252168 is currently recruiting now. Last updated 9 April 2025.

Last reviewed 2025-04-09 · How we verify

NCT06252168: RAMI-Tomsk

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry of Acute Myocardial Infarction

Recruiting now Last updated 9 April 2025

What this trial tests

trial in Myocardial Infarction, Acute in 97,500 participants. Currently enrolling.

Timeline

1 January 1984

Primary endpoint
31 December 2049

31 December 2050

Quick facts

Lead sponsor	Tomsk National Research Medical Center of the Russian Academy of Sciences
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	97,500
Start date	1 January 1984
Primary completion	31 December 2049
Estimated completion	31 December 2050
Sites	1 location across Russia

Conditions studied

Myocardial Infarction, Acute — all drugs for Myocardial Infarction, Acute →

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences

Who can join

20 and older, any sex, with Myocardial Infarction, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Registry of Acute Myocardial Infarction (RAMI) aims at regular and centralized acquiring and processing standard information about verified and suspected cases of acute myocardial infarction (AMI), monitoring of AMI cases, and establishing AMI diagnosis based on standard diagnostic criteria by doctors involved in the registry. The RAMI obtains data from all medical institutions, which could potentially document any cases of suspected AMI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myocardial Infarction, Acute

Currently open trials in the same condition.

NCT07181317 — WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up · recruiting
NCT07008391 — High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS · NA · recruiting
NCT05759078 — Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Defici · Phase 4 · recruiting
NCT05198791 — Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries. · Phase 2 · recruiting
NCT04968808 — Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) · NA · recruiting

Other Tomsk National Research Medical Center of the Russian Academy of Sciences trials

Trials by the same sponsor.

NCT07457541 — Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI · Phase 1 · active not recruiting
NCT07475390 — 99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging · NA · active not recruiting
NCT07292571 — Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107 · Phase 2 · enrolling by invitation
NCT07275463 — [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression · Phase 2 · enrolling by invitation
NCT07018895 — Personalized Hypoxic-hyperoxic Preconditioning in Elderly People · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06252168 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tomsk National Research Medical Center of the Russian Academy of Sciences
Last refreshed: 9 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06252168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing